Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture
Introduction species (spp.) are among the leading agents of bloodstream infections. Candidemias are a major cause of morbidity and mortality. Having an understanding of epidemiology and antifungal susceptibility patterns in each center is crucial in guiding the management of candidemia. In this stu...
Gespeichert in:
Veröffentlicht in: | Curēus (Palo Alto, CA) CA), 2023-04, Vol.15 (4), p.e38183-e38183 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e38183 |
---|---|
container_issue | 4 |
container_start_page | e38183 |
container_title | Curēus (Palo Alto, CA) |
container_volume | 15 |
creator | Dalyan Cilo, Burcu |
description | Introduction
species (spp.) are among the leading agents of bloodstream infections. Candidemias are a major cause of morbidity and mortality. Having an understanding of
epidemiology and antifungal susceptibility patterns in each center is crucial in guiding the management of candidemia. In this study, the species distribution and antifungal susceptibility of
spp. isolated from blood culture at the University of Health Sciences, Bursa Yuksek Ihtisas Training & Research Hospital were examined and the first data on the epidemiology of candidemia in our center were presented. Methods A total of 236
strains isolated from blood cultures in our hospital over a four-year period were analyzed and their antifungal susceptibilities were studied retrospectively. Strains were identified at the species complex (SC) level by the germ tube test, morphology in cornmeal-tween 80 medium, and the automated VITEK 2 Compact (bioMérieux, Marcy-l'Étoile, France) system. Antifungal susceptibility tests were performed on VITEK 2 Compact (bioMérieux, Marcy-l'Étoile, France) system. The susceptibilities of the strains to fluconazole, voriconazole, micafungin, and amphotericin B were determined according to Clinical and Laboratory Standards Institute (CLSI) guidelines and epidemiologic cut-off values. Results Of the
strains, 131 were
(55.5%), 40 were
SC (16.9%), 21 were
(8.9%), 19 were
SC (8.1%), eight were
(3.4%), seven were
(3.0%), six were
(2.6%), two were
(0.8%) and two were
(0.8%). Amphotericin B resistance was not detected in
strains. Micafungin susceptibility was 98.3%, and four
SC strains (10%) were intermediate (I) to micafungin. Fluconazole susceptibility was 87.2%. Apart from
strains which intrinsically resistant to fluconazole, three
(7.5%), one
SC (5.3%) strain were resistant (R) to fluconazole, and one
(12.5%) strain was wild-type (WT). Voriconazole susceptibility of
strains was 98.6%. Two
SC strains were I to voriconazole, while one strain was R. Conclusion In this study, the first epidemiological data of candidemia agents in our hospital were presented. It was determined that rare and naturally resistant species did not cause any problem in our center yet.
SC strains showed decreased susceptibility to fluconazole, whereas
strains were highly susceptible to the four antifungals tested. Close monitoring of these data will help guide the treatment of candidemia. |
doi_str_mv | 10.7759/cureus.38183 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10224711</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2821276938</sourcerecordid><originalsourceid>FETCH-LOGICAL-c300t-1d77a540680be70171e25de3360e37f1746f7307076c6e033551355b054173d33</originalsourceid><addsrcrecordid>eNpdkc1LxDAQxYMoKurNswS8eHDXSdJ2uifR9RMWPKjnkLapRrLNmg_B_96sq6IehhmY3zzm8QjZZzBGLCcnbfI6hbGoWS3WyDZnVT3Kc7H-a94ieyG8AAAD5ICwSbYE8pKXE9wm7f1Ct0YHemFC9KZJ0biBqqGjZ0M0fRqelKX3KbR6EU1jrIlL2PV0mhnTKfp9fxucVVF39Mq7OT23znV0mmzMD-6SjV7ZoPe--g55vLp8mN6MZnfXt9Oz2agVAHHEOkRVFlDV0GgEhkzzstNCVKAF9gyLqkeRDWDVVhqEKEuWq4GyYCg6IXbI6Up3kZq57lo9RK-sXHgzV_5dOmXk381gnuWTe5MMOC-Qsaxw9KXg3WvSIcq5ydatVYN2KUhec5gg8Ipn9PAf-uKSH7K_JcU4VhNRZ-p4RbXeheB1__MNA7lMUK4SlJ8JZvzgt4Mf-Dsv8QEk9pc5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2821276938</pqid></control><display><type>article</type><title>Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture</title><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Dalyan Cilo, Burcu</creator><creatorcontrib>Dalyan Cilo, Burcu</creatorcontrib><description>Introduction
species (spp.) are among the leading agents of bloodstream infections. Candidemias are a major cause of morbidity and mortality. Having an understanding of
epidemiology and antifungal susceptibility patterns in each center is crucial in guiding the management of candidemia. In this study, the species distribution and antifungal susceptibility of
spp. isolated from blood culture at the University of Health Sciences, Bursa Yuksek Ihtisas Training & Research Hospital were examined and the first data on the epidemiology of candidemia in our center were presented. Methods A total of 236
strains isolated from blood cultures in our hospital over a four-year period were analyzed and their antifungal susceptibilities were studied retrospectively. Strains were identified at the species complex (SC) level by the germ tube test, morphology in cornmeal-tween 80 medium, and the automated VITEK 2 Compact (bioMérieux, Marcy-l'Étoile, France) system. Antifungal susceptibility tests were performed on VITEK 2 Compact (bioMérieux, Marcy-l'Étoile, France) system. The susceptibilities of the strains to fluconazole, voriconazole, micafungin, and amphotericin B were determined according to Clinical and Laboratory Standards Institute (CLSI) guidelines and epidemiologic cut-off values. Results Of the
strains, 131 were
(55.5%), 40 were
SC (16.9%), 21 were
(8.9%), 19 were
SC (8.1%), eight were
(3.4%), seven were
(3.0%), six were
(2.6%), two were
(0.8%) and two were
(0.8%). Amphotericin B resistance was not detected in
strains. Micafungin susceptibility was 98.3%, and four
SC strains (10%) were intermediate (I) to micafungin. Fluconazole susceptibility was 87.2%. Apart from
strains which intrinsically resistant to fluconazole, three
(7.5%), one
SC (5.3%) strain were resistant (R) to fluconazole, and one
(12.5%) strain was wild-type (WT). Voriconazole susceptibility of
strains was 98.6%. Two
SC strains were I to voriconazole, while one strain was R. Conclusion In this study, the first epidemiological data of candidemia agents in our hospital were presented. It was determined that rare and naturally resistant species did not cause any problem in our center yet.
SC strains showed decreased susceptibility to fluconazole, whereas
strains were highly susceptible to the four antifungals tested. Close monitoring of these data will help guide the treatment of candidemia.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.38183</identifier><identifier>PMID: 37252597</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Antifungal agents ; Automation ; Epidemiology ; Fungal infections ; Infectious Disease ; Laboratories</subject><ispartof>Curēus (Palo Alto, CA), 2023-04, Vol.15 (4), p.e38183-e38183</ispartof><rights>Copyright © 2023, Dalyan Cilo et al.</rights><rights>Copyright © 2023, Dalyan Cilo et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2023, Dalyan Cilo et al. 2023 Dalyan Cilo et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c300t-1d77a540680be70171e25de3360e37f1746f7307076c6e033551355b054173d33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224711/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224711/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37252597$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dalyan Cilo, Burcu</creatorcontrib><title>Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Introduction
species (spp.) are among the leading agents of bloodstream infections. Candidemias are a major cause of morbidity and mortality. Having an understanding of
epidemiology and antifungal susceptibility patterns in each center is crucial in guiding the management of candidemia. In this study, the species distribution and antifungal susceptibility of
spp. isolated from blood culture at the University of Health Sciences, Bursa Yuksek Ihtisas Training & Research Hospital were examined and the first data on the epidemiology of candidemia in our center were presented. Methods A total of 236
strains isolated from blood cultures in our hospital over a four-year period were analyzed and their antifungal susceptibilities were studied retrospectively. Strains were identified at the species complex (SC) level by the germ tube test, morphology in cornmeal-tween 80 medium, and the automated VITEK 2 Compact (bioMérieux, Marcy-l'Étoile, France) system. Antifungal susceptibility tests were performed on VITEK 2 Compact (bioMérieux, Marcy-l'Étoile, France) system. The susceptibilities of the strains to fluconazole, voriconazole, micafungin, and amphotericin B were determined according to Clinical and Laboratory Standards Institute (CLSI) guidelines and epidemiologic cut-off values. Results Of the
strains, 131 were
(55.5%), 40 were
SC (16.9%), 21 were
(8.9%), 19 were
SC (8.1%), eight were
(3.4%), seven were
(3.0%), six were
(2.6%), two were
(0.8%) and two were
(0.8%). Amphotericin B resistance was not detected in
strains. Micafungin susceptibility was 98.3%, and four
SC strains (10%) were intermediate (I) to micafungin. Fluconazole susceptibility was 87.2%. Apart from
strains which intrinsically resistant to fluconazole, three
(7.5%), one
SC (5.3%) strain were resistant (R) to fluconazole, and one
(12.5%) strain was wild-type (WT). Voriconazole susceptibility of
strains was 98.6%. Two
SC strains were I to voriconazole, while one strain was R. Conclusion In this study, the first epidemiological data of candidemia agents in our hospital were presented. It was determined that rare and naturally resistant species did not cause any problem in our center yet.
SC strains showed decreased susceptibility to fluconazole, whereas
strains were highly susceptible to the four antifungals tested. Close monitoring of these data will help guide the treatment of candidemia.</description><subject>Antifungal agents</subject><subject>Automation</subject><subject>Epidemiology</subject><subject>Fungal infections</subject><subject>Infectious Disease</subject><subject>Laboratories</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkc1LxDAQxYMoKurNswS8eHDXSdJ2uifR9RMWPKjnkLapRrLNmg_B_96sq6IehhmY3zzm8QjZZzBGLCcnbfI6hbGoWS3WyDZnVT3Kc7H-a94ieyG8AAAD5ICwSbYE8pKXE9wm7f1Ct0YHemFC9KZJ0biBqqGjZ0M0fRqelKX3KbR6EU1jrIlL2PV0mhnTKfp9fxucVVF39Mq7OT23znV0mmzMD-6SjV7ZoPe--g55vLp8mN6MZnfXt9Oz2agVAHHEOkRVFlDV0GgEhkzzstNCVKAF9gyLqkeRDWDVVhqEKEuWq4GyYCg6IXbI6Up3kZq57lo9RK-sXHgzV_5dOmXk381gnuWTe5MMOC-Qsaxw9KXg3WvSIcq5ydatVYN2KUhec5gg8Ipn9PAf-uKSH7K_JcU4VhNRZ-p4RbXeheB1__MNA7lMUK4SlJ8JZvzgt4Mf-Dsv8QEk9pc5</recordid><startdate>20230427</startdate><enddate>20230427</enddate><creator>Dalyan Cilo, Burcu</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230427</creationdate><title>Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture</title><author>Dalyan Cilo, Burcu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c300t-1d77a540680be70171e25de3360e37f1746f7307076c6e033551355b054173d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antifungal agents</topic><topic>Automation</topic><topic>Epidemiology</topic><topic>Fungal infections</topic><topic>Infectious Disease</topic><topic>Laboratories</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dalyan Cilo, Burcu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dalyan Cilo, Burcu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2023-04-27</date><risdate>2023</risdate><volume>15</volume><issue>4</issue><spage>e38183</spage><epage>e38183</epage><pages>e38183-e38183</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Introduction
species (spp.) are among the leading agents of bloodstream infections. Candidemias are a major cause of morbidity and mortality. Having an understanding of
epidemiology and antifungal susceptibility patterns in each center is crucial in guiding the management of candidemia. In this study, the species distribution and antifungal susceptibility of
spp. isolated from blood culture at the University of Health Sciences, Bursa Yuksek Ihtisas Training & Research Hospital were examined and the first data on the epidemiology of candidemia in our center were presented. Methods A total of 236
strains isolated from blood cultures in our hospital over a four-year period were analyzed and their antifungal susceptibilities were studied retrospectively. Strains were identified at the species complex (SC) level by the germ tube test, morphology in cornmeal-tween 80 medium, and the automated VITEK 2 Compact (bioMérieux, Marcy-l'Étoile, France) system. Antifungal susceptibility tests were performed on VITEK 2 Compact (bioMérieux, Marcy-l'Étoile, France) system. The susceptibilities of the strains to fluconazole, voriconazole, micafungin, and amphotericin B were determined according to Clinical and Laboratory Standards Institute (CLSI) guidelines and epidemiologic cut-off values. Results Of the
strains, 131 were
(55.5%), 40 were
SC (16.9%), 21 were
(8.9%), 19 were
SC (8.1%), eight were
(3.4%), seven were
(3.0%), six were
(2.6%), two were
(0.8%) and two were
(0.8%). Amphotericin B resistance was not detected in
strains. Micafungin susceptibility was 98.3%, and four
SC strains (10%) were intermediate (I) to micafungin. Fluconazole susceptibility was 87.2%. Apart from
strains which intrinsically resistant to fluconazole, three
(7.5%), one
SC (5.3%) strain were resistant (R) to fluconazole, and one
(12.5%) strain was wild-type (WT). Voriconazole susceptibility of
strains was 98.6%. Two
SC strains were I to voriconazole, while one strain was R. Conclusion In this study, the first epidemiological data of candidemia agents in our hospital were presented. It was determined that rare and naturally resistant species did not cause any problem in our center yet.
SC strains showed decreased susceptibility to fluconazole, whereas
strains were highly susceptible to the four antifungals tested. Close monitoring of these data will help guide the treatment of candidemia.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>37252597</pmid><doi>10.7759/cureus.38183</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2168-8184 |
ispartof | Curēus (Palo Alto, CA), 2023-04, Vol.15 (4), p.e38183-e38183 |
issn | 2168-8184 2168-8184 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10224711 |
source | PubMed Central; PubMed Central Open Access |
subjects | Antifungal agents Automation Epidemiology Fungal infections Infectious Disease Laboratories |
title | Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T02%3A38%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Species%20Distribution%20and%20Antifungal%20Susceptibilities%20of%20Candida%20Species%20Isolated%20From%20Blood%20Culture&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Dalyan%20Cilo,%20Burcu&rft.date=2023-04-27&rft.volume=15&rft.issue=4&rft.spage=e38183&rft.epage=e38183&rft.pages=e38183-e38183&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.38183&rft_dat=%3Cproquest_pubme%3E2821276938%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2821276938&rft_id=info:pmid/37252597&rfr_iscdi=true |